Yubal, Aljen .
HRN: 25-47-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
CEFUROXIME 500MG (TAB)
10/24/2025
10/30/2025
PO
500 Mg
BID
Sp RMLE And Repair
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes